AVDL vs ESS · rev $169.1M vs P/E 31, rev $489.0M
Avadel Pharmaceuticals PLC (AVDL) versus Essex Property Trust Inc (ESS) — a side-by-side from cached financials, not a winner call.
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
Latest reported ESS revenue for 2026-06-30 was $489.0M. Net income was $66.9M. Revenue was up 0.9% from 2026-03-31 to 2026-06-30. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
AVDL currently screens at market cap $968.5M. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Not investment advice. Open the AVDL and ESS stock pages for the full models.
Not investment advice.